A Clinical Study of Fundus OCTA for the Identification of CMD

Sponsor
Peking University First Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05743140
Collaborator
(none)
400
14

Study Details

Study Description

Brief Summary

Coronary microvascular dysfunction (CMD) carries an increased risk of adverse cardiovascular clinical outcomes. The association between fundus microcirculation changes and coronary microcirculation is not well understood. Optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) is a new type of optical diagnostic imaging technology for non-invasive detection, which can perform multi-dimensional quantitative assessment of fundus microcirculation. In this study, investigators intend to use the coronary angiography-derived index of microvascular resistance (caIMR) to screen patients with CMD, explore the relationship between relevant parameters based on OCT and OCTA measurements and caIMR, and evaluate the feasibility and clinical value of non-invasive identification of CMD through fundus OCT and OCTA.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: CaIMR

Detailed Description

Coronary microvascular dysfunction (CMD) is defined as the clinical syndrome of angina and electrocardiographic ischemic changes in the absence of obstructive coronary artery disease. CMD carries an increased risk of adverse cardiovascular clinical outcomes. Assessment of CMD is performed with different diagnostic modalities, including nuclear myocardial scintigraphy, cardiac magnetic resonance, doppler echocardiography, and coronary microcirculation resistance index techniques. However, current examination techniques have limitations such as radiation risk, high cost, and time-consuming, so they cannot be widely screened in the population. Previous studies have shown that fundus vascular changes were strongly associated with cardiovascular events, but the correlation between fundus microcirculation changes and coronary microcirculation is not well understood. Optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) is a new type of optical diagnostic imaging technology for non-invasive detection, which use infrared light projection onto fundus tissue to achieve real-time tomographic section imaging, which can perform multi-dimensional quantitative assessment of fundus microcirculation. In this study, investigators intend to use the coronary angiography-derived index of microvascular resistance (caIMR) to screen patients with CMD, explore the relationship between relevant parameters based on OCT and OCTA measurements and caIMR, and evaluate the feasibility and clinical value of non-invasive identification of CMD through fundus OCT and OCTA.

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
A Clinical Study of Fundus Optical Coherence Tomography Angiography for the Identification of Coronary Microvascular Diseases
Anticipated Study Start Date :
Mar 3, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
CMD group, Non-CMD group

CMD group: participants whose CaIMR shows ≥25U. Non-CMD group: participants whose CaIMR less than 25U.

Diagnostic Test: CaIMR
Investigators diagnose CMD with CaIMR. Investigators use OCT and OCTA to analyze the fundus microcirculation quantitatively.
Other Names:
  • OCT
  • OCTA
  • Outcome Measures

    Primary Outcome Measures

    1. Diagnostic accuracy of fundus OCT and OCTA examinations for coronary microvascular disease [2023.3-2024.5]

      Investigators intend to use these indicators to assess the diagnostic accuracy of fundus OCT and OCTA for CMD: area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patients who underwent coronary angiography in the Department of Cardiology, Peking University First Hospital;

    2. Complete baseline clinical information;

    3. Subject who have coronary angiography results, which shows coronary stenosis < 50%;

    4. Older than 18 years;

    5. Subjects who have signed informed consent.

    Exclusion Criteria:
    1. Present serious fundus disease

    2. Severe cataract and other ophthalmic diseases, which affect imaging quality;

    3. Target coronary vessels provide collateral circulation for chronic complete occlusive lesions;

    4. The target coronary angiography agent is poorly filled, overlapped, or severely distorted, and cannot fully expose the location of the lesion;

    5. Coronary angiography images are of poor quality and cannot be identified;

    6. Active bleeding state;

    7. Severe renal insufficiency, contrast agent allergy, and unable to perform coronary angiography.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Peking University First Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    ZHENG Bo, associate professor, Peking University First Hospital
    ClinicalTrials.gov Identifier:
    NCT05743140
    Other Study ID Numbers:
    • ZHENG Bo
    First Posted:
    Feb 24, 2023
    Last Update Posted:
    Feb 24, 2023
    Last Verified:
    Feb 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by ZHENG Bo, associate professor, Peking University First Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 24, 2023